Alzheimer Disease Clinical Trials in Barcelona
6 recruitingBarcelona, Spain
Showing 1–6 of 6 trials
Recruiting
Phase 3
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
DementiaBrain DiseasesCentral Nervous System Diseases+6 more
Eli Lilly and Company1,500 enrolled141 locationsNCT05508789
Recruiting
Longitudinal Early-onset Alzheimer's Disease Study Protocol
Early-Onset Alzheimer DiseaseAlzheimer DiseaseMild Cognitive Impairment
Indiana University850 enrolled23 locationsNCT03507257
Recruiting
Not Applicable
Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia
DementiaAlzheimer DiseaseCommunication Disorders+11 more
University of Texas at Austin60 enrolled3 locationsNCT05741853
Recruiting
Phase 1
Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease Participants
Alzheimer DiseaseMild Cognitive Impairment
Novartis Pharmaceuticals36 enrolled10 locationsNCT05469360
Recruiting
Trial-Ready Cohort-Down Syndrome (TRC-DS)
DementiaAlzheimer DiseaseDown Syndrome
University of Southern California450 enrolled20 locationsNCT04165109
Recruiting
Multidisciplinary Expert System for the Assessment & Management of Complex Brain Disorders
DementiaEpilepsyHealthy+3 more
Neurological Institute of Athens350 enrolled4 locationsNCT05171725